Royalty-driven Model delivers Strong Margin Expansion and Cash Generation; Leadership Transition positions Company for Next Phase of GrowthAll dollar amounts are expressed in Canadian currency(1) Please refer to "non-IFRS and other financial performance measures" in this press release Fiscal 2025 Highlights Record total revenues of $42.8 million, up 8% vs. FY 2024Record royalties of $11 million, up 27% vs. FY 2024Adjusted EBITDA1 of $7.3 million, or 17% of total revenues, up 9 pts vs. FY 2024Net profit of $ ...

JERICHO, N.Y., June 10, 2025 (GLOBE NEWSWIRE) -- Nathan's Famous, Inc. (“Nathan’s”, the “Company”, “we”, “us” or “our”) (NASDAQ:NATH) today reported results for its fiscal year and fourth quarter ended March 30, 2025. Effective June 10, 2025, the Board of Directors declared its first quarterly cash dividend for fiscal 2026 of $0.50 per share, which is payable on July 1, 2025 to shareholders of record at the close of business on June 23, 2025. For the fiscal year ended March 30, 2025: Revenues were $148,182, ...

Reaffirms Fiscal 2025 Net Sales and Earnings Outlook*SAN DIEGO, June 5, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced its first quarter 2025 financial results.Q1 2025 Overview Net sales of $1.5 billion decreased 2.3% year over year in line with the company's first quarter outlook Comparable sales decreased 1.3% year over year Gross profit margin expanded approximately 30 basis points to 38.2% as a percentage of net sales Operating Income improved $33.1 million t ...

Core Viewpoint - EuroDry Ltd. reported a challenging first quarter of 2025, with significant declines in revenues and profitability due to low charter rates and market volatility, particularly influenced by external economic factors and geopolitical tensions [4][6][9]. Financial Performance - Total net revenues for Q1 2025 were $9.2 million, a decrease of 36.2% compared to $14.4 million in Q1 2024 [6][9]. - The average time charter equivalent rate dropped by 42.5% to $7,167 per day in Q1 2025 from $12,455 per day in Q1 2024 [6][9]. - Adjusted EBITDA for Q1 2025 was $(1.0) million, down from $2.1 million in Q1 2024 [8][17]. - The net loss attributable to controlling shareholders was $3.7 million, or $1.35 loss per share, compared to a net loss of $1.8 million, or $0.65 loss per share, in the same period of 2024 [16][18]. Operational Insights - The company operated an average of 12.8 vessels in Q1 2025, compared to 13.0 vessels in Q1 2024 [9][23]. - Vessel operating expenses increased to $6.6 million in Q1 2025 from $6.2 million in Q1 2024, primarily due to higher costs for spare parts and maintenance [7][10]. - The fleet utilization rate was 97.4% in Q1 2025, slightly down from 98.1% in Q1 2024 [24]. Strategic Decisions - The company opted not to lock vessels into longer duration charters at unprofitable levels, instead pursuing short-term trip charters to capitalize on potential market recoveries [5]. - EuroDry sold the M/V Tasos for approximately $5 million, resulting in a gain on sale of $2.1 million [13]. Market Conditions - The charter market was described as the lowest since the early COVID pandemic, with a slight rebound in April and May that was insufficient to restore profitability [4]. - The demand side of the supply/demand equation remains volatile, influenced by the steel industry's weakness and economic growth uncertainties in China, as well as ongoing geopolitical conflicts [4]. Fleet Profile - EuroDry's fleet consists of 12 vessels with a total cargo capacity of 843,402 dwt, including 4 Panamax, 5 Ultramax, and 2 Kamsarmax drybulk carriers [57]. - Two Ultramax vessels are under construction, expected to be delivered in 2027, which will increase the fleet to 14 vessels with a total capacity of 970,402 dwt [21][57].

SINGAPORE, June 05, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Total revenue was $78.0 million, a decrease of 46.0% from $144.4 million in the same period of 2024. This decrease was primarily attributable to the Bitcoin (“BTC”) mining “halving event” occurred in April 2024, increase i ...

ChargePoint (CHPT) Q1 2026 Earnings Call June 04, 2025 04:30 PM ET Company Participants John Paolo Canton - Vice President, CommunicationsRick Wilmer - President, CEO & DirectorMansi Khetani - Chief Financial OfficerColin Rusch - Managing Director - Head of Sustainable Growth & Resource Optimization Research Operator Ladies and gentlemen, good afternoon. My name is Kate, and I'll be your conference operator for today. At this time, I would like to welcome everyone to the ChargePoint First Quarter Fiscal twe ...

Record Services Revenues WATERLOO, Ontario and ATLANTA, June 04, 2025 (GLOBE NEWSWIRE) -- The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2026 first quarter (Q1FY26). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance with US Generally Accepted Accounting Principles (GAAP). "Our first quarter of fiscal 2026 showed strong annual growth, consistent with our communicated plans, ...

PaySign Inc. Conference Call Summary Company Overview - **Company Name**: PaySign Inc. (Ticker: PAYS) - **Industry**: Payment services, primarily in healthcare - **Headquarters**: Southern Nevada, near Las Vegas - **Incorporation Year**: 1995 - **Public Listing**: Went public through a reverse merger in 2018 Core Business Segments - **Healthcare Payments**: Predominantly provides payment services to the healthcare industry, including patient affordability programs and plasma donor payments [5][9] - **Patient Affordability Programs**: Helps patients cover copays for expensive medications, with a focus on reducing abandonment rates for prescriptions [9][10] - **Plasma Industry**: Engaged in electronic payments for plasma donation centers, holding a 40% market share in the U.S. [8][11] Financial Performance - **Revenue**: - 2024 projected revenue: $58.4 million - 2023 revenue: $87 million from plasma business and $12.7 million from patient affordability [11][16] - Patient affordability business expected to grow at least 135% in 2024 [11] - **Adjusted EBITDA**: $13 million for the trailing twelve months, with margins improving [16][34] - **Cash Position**: $111 million in cash, with zero debt [15][34] - **Gross Margins**: Increased to 62.9% from 53% year-over-year [14] Market Dynamics - **Plasma Market**: - U.S. provides over 75% of the world's plasma, with a normal growth rate of about 5% annually [8][26] - Anticipated decline of 8-10% in plasma business revenue due to operational adjustments post-COVID [26] - **Patient Affordability Market**: - Total Addressable Market (TAM) estimated at over $500 million, indicating significant growth potential [29] Strategic Initiatives - **Acquisition of Gamma Innovation**: - Acquired for $16 million, aimed at enhancing software capabilities in the plasma industry [28][30] - **Dynamic Business Rules Technology**: - Proprietary technology that saved customers over $100 million in claims in 2024, expected to double in 2025 [22] Leadership and Expertise - **Senior Leadership**: Comprised of individuals with extensive backgrounds in banking, payments, and healthcare, enhancing domain expertise [13][39] - **Analyst Coverage**: Covered by five firms, all with buy or equivalent ratings, target prices ranging from $6 to $8 [35] Additional Insights - **Customer Engagement**: The company emphasizes direct partnerships with pharmaceutical companies, enhancing payment capabilities and transparency [42][44] - **Operational Efficiency**: The call center operates at breakeven, indicating effective cost management [17] - **Regulatory Environment**: The company operates primarily in the U.S. market, with limited applicability of its services outside due to different healthcare systems [37] Conclusion PaySign Inc. is positioned for growth in the healthcare payment sector, with strong financials, innovative technology, and a strategic focus on expanding its market share in both the plasma and patient affordability segments. The leadership team's expertise and recent acquisitions further bolster its competitive advantage in a rapidly evolving industry.

Key Takeaways CVNA reported record Q1 2025 adjusted EBITDA of $488M, up $253M year over year with an 11.5% margin. Approximately 80% of adjusted EBITDA converted into GAAP operating income, hitting 9.3% margin. CVNA expects sequential EBITDA growth in Q2 and aims for 13.5% margins over the next five to ten years.Carvana Co. (CVNA) achieved a record-breaking adjusted EBITDA of $488 million in the first quarter of 2025, which increased $253 million year over year. The company's adjusted EBITDA margin reache ...

Mama's Creations (MAMA) Q1 2026 Earnings Call June 03, 2025 04:30 PM ET Company Participants Adam Michaels - CEO & ChairmanAnthony Gruber - CFOAnthony Vendetti - Executive Managing Director Conference Call Participants Ryan Meyers - Senior Research AnalystEric Des Lauriers - Senior Research AnalystGeorge Kelly - Managing Director, Senior Research Analyst Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Mama's Creations First Quarter Fiscal twenty twenty six Earnings C ...